Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

The president of the union representing workers at the CISSS de Laval (FSSS–CSN) said she was “insulted and dumbfounded” by ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...